The role of a specific protein, PKA (protein kinase A), is essential in some types of cells for autophagy. Autophagy is the physiological process through which our cells get rid of damaged components. This discovery could open new therapeutic strategies for degenerative diseases and tumors. This is the result achieved by the recently published study, conducted by […]
READ MOREThree high profiles to choose an equally high profile: the new VIMM Scientific Director. The Foundation for Advanced Biomedical Research has chosen Professor Alberto Mantovani, Director of Humanitas Research Institute of Milan, Professor Maria Grazia Roncarolo, Director of the Institute for Stem Cell Biology and Regenerative Medicine of Stanford CA, and Prof. Giuseppe Remuzzi, Director […]
READ MOREVIMM postdoctoral researcher affiliated with Luca Scorrano’s group, Akiko Omori, won a research grant from the Umberto Veronesi Foundation, with an experimental project against prostate tumors. More specifically, Dr. Omori’s goal is to identify a new therapeutic approach for patients affected by prostate tumors that do not resolve with the conventional administration of antiandrogenic drugs. […]
READ MOREFighting a genetic eye disease that leads to progressive blindness: Schnyder’s corneal dystrophy (SCD). This is the aim of Massimo Santoro‘s research project, who is professor at University of Padua and Principal Investigator at Advanced Biomedical Research Foundation – VIMM. Telethon Foundation has guaranteed its team a loan of 240 thousand euros for the three-year […]
READ MOREAt VIMM, even scientific findings seem to believe in gender equality. After the pioneering study conducted by professors Francesco Pagano and Andrea Alimonti, which reveals a lower risk of SARS-CoV-2 infection in men with prostate cancer undergoing androgen deprivation therapies, a new VIMM research highlights the same dynamics also in case of women. Among the […]
READ MORENeurons that mature too quickly underlie brain pathologies, particularly human intellectual disability. At first glance, it might seem counterintuitive. Instead it is the important result obtained from a study conducted by Claudia Lodovichi‘s team, Principal Investigator at VIMM and researcher at the Institute of Neuroscience (CNR), just published in PNAS-Proceedings of the National Academy of […]
READ MOREVIMM Trainee Seminars are weekly short seminars held by our junior trainees on Fridays. The spirit of the initiative is to offer our students and postdocs a peer-to-peer time to networking, improve communication skills and get feedbacks on ongoing projects. In addition, during the same time slot, we will now have bi-monthly “Meet-the-expert” sessions, where senior personnel will illustrate some of […]
READ MOREEmanuela Zuccaro, researcher of the VIMM of the group of Maria Pennuto. Her project, “MOVER” wins the 2020 call of the AriSLA Foundation (Italian Research Foundation for Amyotrophic Lateral Sclerosis), issued to select the best Italian research projects in the field of SLA. It will cover a period of 12 months.
READ MOREVIMM scientist Milena Bellin receives 2 million euros from the European Research Council (ERC). The ERC Consolidator Grant is for promising researchers with seven to 12 years of experience since competing their PhD. They can use the grant of up to 2m euros to fund their team of researchers and support staff for a period […]
READ MOREIn a study just published in Cancer Cell, the professor Alimonti and his team demonstrated the role of TIMP1 gene that, if present in senescent cells, can counteract the metastatic process in prostate cancer.
READ MORE